Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422331
Status:
UNKNOWN
Last Update Posted:
2007-08-14
First Post:
2007-01-11
Brief Title:
Safety and Efficacy Study of Lithium in Bipolar Disorder
Sponsor:
JDS Pharmaceuticals
Organization:
JDS Pharmaceuticals
Study Overview
Official Title:
Double-Blind Randomized Placebo-Controlled Parallel-Group Multicenter Efficacy and Safety Study of Lithium in Bipolar I Disorder
Status:
UNKNOWN
Status Verified Date:
2007-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether Lithium is safe and effective in the treatment of Bipolar I Disorder subjects with symptoms of acute mania
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Lithium TEAM-1 Study | None | None | None |